Jennifer A. Nelson - 22 Nov 2024 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGAQ)

Role
Chief Scientific Officer
Signature
/s/ Jennifer A. Nelson
Issuer symbol
OMGAQ
Transactions as of
22 Nov 2024
Net transactions value
$0
Form type
4
Filing time
26 Nov 2024, 18:31:30 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMGA Stock Option (Right to Buy) Award $0 +110,000 $0.000000 110,000 22 Nov 2024 Common Stock 110,000 $0.7860 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable with respect to 25% of the underlying shares on November 15, 2025 and in twelve (12) equal quarterly installments thereafter such that the option will become fully vested and exercisable on November 15, 2028, subject to the Reporting Person's continued service to the Issuer through each such vesting date.